非处方药：概述 - Suppr

Suppr

超能文献

Nonprescription drugs: an overview.

作者信息

Hodes B

出版信息

Int J Health Serv. 1974 Winter;4(1):125-30. doi: 10.2190/C9CD-1PRB-G60Y-XPVG.

DOI:10.2190/C9CD-1PRB-G60Y-XPVG

PMID:4829892

Abstract

摘要

相似文献

Nonprescription drugs: an overview.

Int J Health Serv. 1974 Winter;4(1):125-30. doi: 10.2190/C9CD-1PRB-G60Y-XPVG.

The dangers of self-dosing.

US News World Rep. 1998 Jul 13;125(2):58.

The drug regulatory system of the United States Food and Drug Administration: a defense of current requirements for safety and efficacy.

Int J Health Serv. 1974 Winter;4(1):95-107. doi: 10.2190/TW4Q-WEDA-2Q7V-RHAH.

From the Food and Drug Administration.

JAMA. 1999 Apr 7;281(13):1164.

Regulatory controversy surrounding ipecac use and misuse.

Am J Hosp Pharm. 1986 Jan;43(1):157-61.

The Food and Drug Administration's over-the-counter drug review: why review OTC drugs?

Fed Proc. 1973 Apr;32(4):1435-7.

Rx-to-OTC switch movement.

Med Care Rev. 1994 Winter;51(4):429-66. doi: 10.1177/107755879405100403.

OTCs and PPIs what is going on here?

Postgrad Med. 1978 Apr;63(4):19-20. doi: 10.1080/00325481.1978.11714797.

Human and veterinary drugs: good manufacturing practices and proposed exemptions for certain OTC products.

Fed Regist. 1978 Sep 29;43(190 Pt 2):45013-89.

Med Clin (Barc). 2013 Nov 16;141(10):454-8. doi: 10.1016/j.medcli.2013.09.008. Epub 2013 Oct 19.

引用本文的文献

Effects of sociodemographic and attitudinal factors on mother-initiated medication behavior for children.

Public Health Rep. 1982 Mar-Apr;97(2):140-9.

A review of over-the-counter drug therapy.

J Community Health. 1979 Fall;5(1):54-66. doi: 10.1007/BF01321571.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Nonprescription drugs: an overview.

Int J Health Serv. 1974 Winter;4(1):125-30. doi: 10.2190/C9CD-1PRB-G60Y-XPVG.

The dangers of self-dosing.

US News World Rep. 1998 Jul 13;125(2):58.

The drug regulatory system of the United States Food and Drug Administration: a defense of current requirements for safety and efficacy.

Int J Health Serv. 1974 Winter;4(1):95-107. doi: 10.2190/TW4Q-WEDA-2Q7V-RHAH.

From the Food and Drug Administration.

JAMA. 1999 Apr 7;281(13):1164.

Regulatory controversy surrounding ipecac use and misuse.

Am J Hosp Pharm. 1986 Jan;43(1):157-61.

The Food and Drug Administration's over-the-counter drug review: why review OTC drugs?

Fed Proc. 1973 Apr;32(4):1435-7.

Rx-to-OTC switch movement.

Med Care Rev. 1994 Winter;51(4):429-66. doi: 10.1177/107755879405100403.

OTCs and PPIs what is going on here?

Postgrad Med. 1978 Apr;63(4):19-20. doi: 10.1080/00325481.1978.11714797.

Human and veterinary drugs: good manufacturing practices and proposed exemptions for certain OTC products.

Fed Regist. 1978 Sep 29;43(190 Pt 2):45013-89.

Med Clin (Barc). 2013 Nov 16;141(10):454-8. doi: 10.1016/j.medcli.2013.09.008. Epub 2013 Oct 19.

引用本文的文献

Effects of sociodemographic and attitudinal factors on mother-initiated medication behavior for children.

Public Health Rep. 1982 Mar-Apr;97(2):140-9.

A review of over-the-counter drug therapy.

J Community Health. 1979 Fall;5(1):54-66. doi: 10.1007/BF01321571.